- Home
- XNCR vs AIV Comparison
XNCR vs AIV Comparison
Compare XNCR & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | AIV |
|---|---|---|
| Founded | 1997 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | XNCR | AIV |
|---|---|---|
| Price | $12.85 | $5.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $22.78 | $10.00 |
| AVG Volume (30 Days) | 794.1K | ★ 2.1M |
| Earning Date | 02-26-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 37.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.72 |
| Revenue | $150,132,000.00 | ★ $210,889,000.00 |
| Revenue This Year | $18.68 | $6.96 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.81 |
| Revenue Growth | 38.16 | ★ 39.67 |
| 52 Week Low | $6.92 | $5.24 |
| 52 Week High | $21.00 | $9.29 |
Technical Indicators
Market Signals| Indicator | XNCR | AIV |
|---|---|---|
| Relative Strength Index (RSI) | 33.77 | 57.04 |
| Support Level | $13.77 | $5.86 |
| Resistance Level | $15.40 | $5.97 |
| Average True Range (ATR) | 0.79 | 0.08 |
| MACD | -0.18 | 0.00 |
| Stochastic Oscillator | 0.00 | 57.14 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About AIV Apartment Investment and Management Company
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.